|
1
|
Vibert E, Canedo L and Adam R: Strategies
to treat primary unresectable colorectal liver metastases. Semin
Oncol. 32 6 Suppl 8:33–39. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kemeny N: Management of liver metastases
from colorectal cancer. Oncology (Williston Park). 20:1161–1176.
2006.PubMed/NCBI
|
|
3
|
Lau WY and Lai EC: Hepatic resection for
colorectal liver metastases. Singapore Med J. 48:635–639.
2007.PubMed/NCBI
|
|
4
|
Taniai N, Akimaru K, Yoshida H and Tajiri
T: Surgical treatment for better prognosis of patients with liver
metastases from colorectal cancer. Hepatogastroenterology.
54:1805–1809. 2007.PubMed/NCBI
|
|
5
|
Foster JH: Treatment of metastatic disease
of the liver: A skeptic's view. Semin Liver Dis. 4:170–179. 1984.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sharma S, Camci C and Jabbour N:
Management of hepatic metastasis from colorectal cancers: An
update. J Hepatobiliary Pancreat Surg. 15:570–580. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zervoudakis A, Boucher T and Kemeny NE:
Treatment options in colorectal liver metastases: Hepatic arterial
infusion. Visc Med. 33:47–53. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chen MS, Li JQ, Zheng Y, Guo RP, Liang HH,
Zhang YQ, Lin XJ and Lau WY: A prospective randomized trial
comparing percutaneous local ablative therapy and partial
hepatectomy for small hepatocellular carcinoma. Ann Surg.
243:321–328. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gillams A, Goldberg N, Ahmed M, Bale R,
Breen D, Callstrom M, Chen MH, Choi BI, de Baere T, Dupuy D, et al:
Thermal ablation of colorectal liver metastases: A position paper
by an international panel of ablation experts, The Interventional
Oncology Sans Frontières meeting 2013. Eur Radiol. 25:3438–3454.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
He N, Jin QN, Wang D, Yang YM, Liu YL,
Wang GB and Tao KX: Radiofrequency ablation vs. hepatic resection
for resectable colorectal liver metastases. J Huazhong Univ Sci
Technolog Med Sci. 36:514–518. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Jiao LR, Apostolopoulos C, Jacob J, Szydlo
R, Johnson N, Tsim N, Habib NA, Coombes RC and Stebbing J: Unique
localization of circulating tumor cells in patients with hepatic
metastases. J Clin Oncol. 27:6160–6165. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Cristofanilli M, Budd GT, Ellis MJ,
Stopeck A, Matera J, Miller MC, Reuben JM, Doyle GV, Allard WJ,
Terstappen LW and Hayes DF: Circulating tumor cells, disease
progression, and survival in metastatic breast cancer. N Engl J
Med. 351:781–791. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Cristofanilli M, Hayes DF, Budd GT, Ellis
MJ, Stopeck A, Reuben JM, Doyle GV, Matera J, Allard WJ, Miller MC,
et al: Circulating tumor cells: A novel prognostic factor for newly
diagnosed metastatic breast cancer. J Clin Oncol. 23:1420–1430.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Budd GT, Cristofanilli M, Ellis MJ,
Stopeck A, Borden E, Miller MC, Matera J, Repollet M, Doyle GV,
Terstappen LW and Hayes DF: Circulating tumor cells versus
imaging-predicting overall survival in metastatic breast cancer.
Clin Cancer Res. 12:6403–6409. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Smith BM, Slade MJ, English J, Graham H,
Lüchtenborg M, Sinnett HD, Cross NC and Coombes RC: Response of
circulating tumor cells to systemic therapy in patients with
metastatic breast cancer: Comparison of quantitative polymerase
chain reaction and immunocytochemical techniques. J Clin Oncol.
18:1432–1439. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Stathopoulou A, Vlachonikolis I, Mavroudis
D, Perraki M, Kouroussis Ch, Apostolaki S, Malamos N, Kakolyris S,
Kotsakis A, Xenidis N, et al: Molecular detection of
cytokeratin-19-positive cells in the peripheral blood of patients
with operable breast cancer: Evaluation of their prognostic
significance. J Clin Oncol. 20:3404–3412. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wu S, Liu S, Liu Z, Huang J, Pu X, Li J,
Yang D, Deng H, Yang N and Xu J: Classification of circulating
tumor cells by epithelial-mesenchymal transition markers. PLoS One.
10:e01239762015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Schneider T, Hoffmann H, Dienemann H,
Herpel E, Heussel CP, Enk AH, Ring S and Mahnke K: immune response
after radiofrequency ablation and surgical resection in nonsmall
cell lung cancer. Semin Thorac Cardiovasc Surg. 28:585–592. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Napoletano C, Taurino F, Biffoni M, De
Majo A, Coscarella G, Bellati F, Rahimi H, Pauselli S, Pellicciotta
I, Burchell JM, et al: RFA strongly modulates the immune system and
anti-tumor immune responses in metastatic liver patients. Int J
Oncol. 32:481–490. 2008.PubMed/NCBI
|
|
20
|
Wang XY, Yu HY, Zhang YY, Wang YP, Feng
XH, Li ZP, Du XJ and Gao W: Serial changes of mean platelet volume
in relation to Killip Class in patients with acute myocardial
infarction and primary percutaneous coronary intervention. Thromb
Res. 135:652–658. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Mazumdar R, Evans P, Culpin R, Bailey J
and Allsup D: The automated monocyte count is independently
predictive of overall survival from diagnosis in chronic
lymphocytic leukaemia and of survival following first-line
chemotherapy. Leuk Res. 37:614–618. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chang YH, Yang SH, Wang TF, Lin TY, Yang
KL and Chen SH: Complete blood count reference values of cord blood
in Taiwan and the influence of gender and delivery route on them.
Pediatr Neonatol. 52:155–160. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li Q, Dai W, Li Y, Xu Y, Li X and Cai S:
Nomograms for predicting the prognostic value of serological tumor
biomarkers in colorectal cancer patients after radical resection.
Sci Rep. 7:463452017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Johnson PJ: The role of serum
alpha-fetoprotein estimation in the diagnosis and management of
hepatocellular carcinoma. Clin Liver Dis. 5:145–159. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ychou M, Duffour J, Kramar A, Gourgou S
and Grenier J: Clinical significance and prognostic value of CA72-4
compared with CEA and CA19-9 in patients with gastric cancer. Dis
Markers. 16:105–110. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ge F, Zhang H, Wang DD, Li L and Lin PP:
Enhanced detection and comprehensive in situ phenotypic
characterization of circulating and disseminated heteroploid
epithelial and glioma tumor cells. Oncotarget. 6:27049–27064. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Liu YK, Hu BS, Li ZL, He X, Li Y and Lu
LG: An improved strategy to detect the epithelial-mesenchymal
transition process in circulating tumor cells in hepatocellular
carcinoma patients. Hepatol Int. 10:640–646. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Si Y, Lan G, Deng Z, Wang Y, Lu Y, Qin Y,
Huang B, Yang Y, Weng J, Han X, et al: Distribution and clinical
significance of circulating tumor cells in nasopharyngeal
carcinoma. Jpn J Clin Oncol. 46:622–630. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Gorges TM, Tinhofer I, Drosch M, Röse L,
Zollner TM, Krahn T and von Ahsen O: Circulating tumour cells
escape from EpCAM-based detection due to epithelial-to-mesenchymal
transition. BMC Cancer. 12:1782012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhang S, Wu T, Peng X, Liu J, Liu F, Wu S,
Liu S, Dong Y, Xie S and Ma S: Mesenchymal phenotype of circulating
tumor cells is associated with distant metastasis in breast cancer
patients. Cancer Manag Res. 9:691–700. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Guan X, Ma F, Liu S, Wu S, Xiao R, Yuan L,
Sun X, Yi Z, Yang H and Xu B: Analysis of the hormone receptor
status of circulating tumor cell subpopulations based on
epithelial-mesenchymal transition: A proof-of-principle study on
the heterogeneity of circulating tumor cells. Oncotarget.
7:65993–66002. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Li TT, Liu H, Li FP, Hu YF, Mou TY, Lin T,
Yu J, Zheng L and Li GX: Evaluation of epithelial-mesenchymal
transitioned circulating tumor cells in patients with resectable
gastric cancer: Relevance to therapy response. World J
Gastroenterol. 21:13259–13267. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Hinz S, Tepel J, Röder C, Kalthoff H and
Becker T: Profile of serum factors and disseminated tumor cells
before and after radiofrequency ablation compared to resection of
colorectal liver metastases-a pilot study. Anticancer Res.
35:2961–2967. 2015.PubMed/NCBI
|
|
34
|
Horiike N, Iuchi H, Ninomiya T, Kawai K,
Kumagi T, Michitaka K, Masumoto T and Onji M: Influencing factors
for recurrence of hepatocellular carcinoma treated with
radiofrequency ablation. Oncol Rep. 9:1059–1062. 2002.PubMed/NCBI
|
|
35
|
Berger-Richardson D and Swallow CJ: Needle
tract seeding after percutaneous biopsy of sarcoma: Risk/benefit
considerations. Cancer. 123:560–567. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Serrano-Gomez SJ, Maziveyi M and Alahari
SK: Regulation of epithelial-mesenchymal transition through
epigenetic and post-translational modifications. Mol Cancer.
15:182016. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Yu M, Bardia A, Wittner BS, Stott SL, Smas
ME, Ting DT, Isakoff SJ, Ciciliano JC, Wells MN, Shah AM, et al:
Circulating breast tumor cells exhibit dynamic changes in
epithelial and mesenchymal composition. Science. 339:580–584. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Massagué J and Obenauf AC: Metastatic
colonization by circulating tumour cells. Nature. 529:298–306.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Galati D and Zanotta S: Hematologic
neoplasms: Dendritic cells vaccines in motion. Clin Immunol.
183:181–190. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Eyles J, Puaux AL, Wang X, Toh B, Prakash
C, Hong M, Tan TG, Zheng L, Ong LC, Jin Y, et al: Tumor cells
disseminate early, but immunosurveillance limits metastatic
outgrowth, in a mouse model of melanoma. J Clin Invest.
120:2030–2039. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
41
|
Takeda K, Hayakawa Y, Smyth MJ, Kayagaki
N, Yamaguchi N, Kakuta S, Iwakura Y, Yagita H and Okumura K:
Involvement of tumor necrosis factor-related apoptosis-inducing
ligand in surveillance of tumor metastasis by liver natural killer
cells. Nat Med. 7:94–100. 2001. View
Article : Google Scholar : PubMed/NCBI
|
